Those are who qualifies for covid antivirals (Pfizer's Paxlovid or Merck's molnupiravir) according to WHO:
Pfizer's Paxlovid will be available to people who:
- Have tested positive for COVID-19 and have not yet been admitted to the hospital and
- Are high risk for developing severe COVID-19 and
- Are 12 years of age or older (and at least 88 pounds).
Merck's molnupiravir will be available to people who:
- Have tested positive for COVID-19 and have not yet been admitted to the hospital and
- Are high risk for developing severe COVID-19 and
- Have no alternative FDA-authorized COVID-19 treatment options accessible to them or that are clinically appropriate for them and
- Are 18 years of age or older